Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Following a strong launch in 2024 with three large oncology practices, Cerula Care, a new oncology behavioral health and care navigation company, announced an oversubscribed Seed funding round of $3.7 ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.

In an interview, Debra Patt, MD, PhD, MBA, FASCO, discusses the priorities of the Community Oncology Alliance as she starts ...

The American Cancer Society estimates for cancer of the uterus in the United States for 2025 are: About 69,120 new cases of cancer of the uterus will be diagnosed. About 13,860 women will die from ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that ...

The Super Bowl ad encourages people to be diligent about regular mammograms to help more women receive early breast cancer diagnoses.

Chaseburg Area Cancer Walk resets its mission to support cancer survivors and research locally, ensuring more funds stay in ...

Diane Simeone, MD, credits her fascination with human biology and dedication as a student athlete with instilling in her a ...